Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab
Article in Lung Cancer (January 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Lung Cancer (January 2024)
Article in Journal of Cachexia Sarcopenia and Muscle (October 2021)
Article in Frontiers in Nutrition (October 2021)